Research & Literature

The impact of glucocorticoid therapy on trabecular bone score in older women.

Paggiosi MA, Peel NF, Eastell R

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015; (26(6)):1773-80 doi:10.1007/s00198-015-3078-1.

Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.

Kenanidis E, Potoupnis ME, Kakoulidis P, et al.

Expert opinion on drug safety 2015; (14(7)):1035-53 doi:10.1517/14740338.2015.1040387.

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice.

Harvey NC, Glüer CC, Binkley N, et al.

Bone 2015; (78()):216-24.

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Adler RA, El-Hajj Fuleihan G, Bauer DC, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2016; (31(1)):16-35 doi:10.1002/jbmr.2708.

Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia.

Achiou Z, Toumi H, Touvier J, et al.

Bone 2015; (81()):691-701 doi:10.1016/j.bone.2015.09.010.

Glucocorticoid-induced osteoporosis.

Briot K, Roux C

RMD open 2015; (1(1)):e000014 doi:10.1136/rmdopen-2014-000014.

Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.

Bours S, de Vries F, van den Bergh JPW, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2016; (27(4)):1603-1610 doi:10.1007/s00198-015-3426-1.

Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.

Amiche MA, Albaum JM, Tadrous M, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2016; (27(5)):1709-18 doi:10.1007/s00198-015-3455-9.

Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.

Joseph RM, Hunter AL, Ray DW, Dixon WG

Seminars in arthritis and rheumatism 2016; (46(1)):133-41.

Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database.

Trijau S, de Lamotte G, Pradel V, et al.

RMD open 2016; (2(2)):e000249 doi:10.1136/rmdopen-2016-000249.

A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology.

Tanner SB, Moore CF

Open access rheumatology : research and reviews 2012; (4()):99-107 doi:10.2147/OARRR.S29000.

Concomitant and previous osteoporotic vertebral fractures.

Lenski M, Büser N, Scherer M

Acta orthopaedica 2017; (88(2)):192-197 doi:10.1080/17453674.2016.1273644.

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Buckley L, Guyatt G, Fink HA, et al.

Arthritis care & research 2017; (69(8)):1095-1110 doi:10.1002/acr.23279.

Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Szulc P, Naylor K, Hoyle NR, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2017; (28(9)):2541-2556 doi:10.1007/s00198-017-4082-4.

Use of bone turnover markers in postmenopausal osteoporosis.

Eastell R, Szulc P

The lancet. Diabetes & endocrinology 2017; (5(11)):908-923 doi:10.1016/S2213-8587(17)30184-5.

Osteoporotic Thoracolumbar Fractures-How Are They Different?-Classification and Treatment Algorithm.

Rajasekaran S, Kanna RM, Schnake KJ, et al.

Journal of orthopaedic trauma 2017; (31 Suppl 4()):S49-S56 doi:10.1097/BOT.0000000000000949.

Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.

Amiche MA, Lévesque LE, Gomes T, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(3)):419-429 doi:10.1002/jbmr.3318.

Glucocorticoids, Inflammation and Bone.

Güler-Yüksel M, Hoes JN, Bultink IEM, Lems WF

Calcified tissue international 2018; (102(5)):592-606 doi:10.1007/s00223-017-0335-7.

Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?

Vargas-Franco JW, Castaneda B, Rédiní F, et al.

Journal of cellular physiology 2018; (233(8)):5696-5715 doi:10.1002/jcp.26465.

Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.

Chan BH, Yee R, Puvanendran R, Ang SB

Singapore medical journal 2018; (59(2)):70-75 doi:10.11622/smedj.2018014.

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.

Saag KG, Wagman RB, Geusens P, et al.

The lancet. Diabetes & endocrinology 2018; (6(6)):445-454 doi:10.1016/S2213-8587(18)30075-5.

Glucocorticoid-induced osteoporosis: an update.

Compston J

Endocrine 2018; (61(1)):7-16 doi:10.1007/s12020-018-1588-2.

Glucocorticoid-Induced Osteoporosis: Management Challenges in Older Patients.

Adler RA

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2019; (22(1)):20-24 doi:10.1016/j.jocd.2018.03.004.

Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid Treatment.

Shen J, Griffith JF, Zhu TY, et al.

The Journal of clinical endocrinology and metabolism 2018; (103(9)):3340-3349 doi:10.1210/jc.2018-00490.

Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study.

Hallmer F, Andersson G, Götrick B, et al.

Oral surgery, oral medicine, oral pathology and oral radiology 2018; (126(6)):477-485 doi:10.1016/j.oooo.2018.08.015.

Vertebral fractures cascade: potential causes and risk factors.

Che H, Breuil V, Cortet B, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(3)):555-563 doi:10.1007/s00198-018-4793-1.

Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis.

Park SY, Gong HS, Kim KM, et al.

Journal of bone metabolism 2018; (25(4)):195-211 doi:10.11005/jbm.2018.25.4.195.

Glucocorticoid-induced osteoporosis: 2019 concise clinical review.

Adami G, Saag KG

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(6)):1145-1156 doi:10.1007/s00198-019-04906-x.

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.

Lorentzon M, Branco J, Brandi ML, et al.

Advances in therapy 2019; (36(10)):2811-2824 doi:10.1007/s12325-019-01063-9.

Understanding Patients' Perspectives and Educational Needs by Type of Osteoporosis in Men and Women and People with Glucocorticosteroid-Induced Osteoporosis: A Qualitative Study to Improve Disease Management.

Beauvais C, Poivret D, Lespessailles E, et al.

Calcified tissue international 2019; (105(6)):589-608 doi:10.1007/s00223-019-00607-z.

Views on glucocorticoid therapy in rheumatology: the age of convergence.

Buttgereit F

Nature reviews. Rheumatology 2020; (16(4)):239-246 doi:10.1038/s41584-020-0370-z.

Pan Arab Osteoporosis Society Guidelines for Osteoporosis Management.

Jassim NA, Adib G, Abdul Rahman YA, et al.

Mediterranean journal of rheumatology 2017; (28(1)):27-32 doi:10.31138/mjr.28.1.27.

Medication-related Osteonecrosis of the Jaw: A Review.

AlDhalaan NA, BaQais A, Al-Omar A

Cureus 2020; (12(2)):e6944 doi:10.7759/cureus.6944.

Management of glucocorticoid-related osteoporotic vertebral fracture.

Wong SPY, Mok CC

Osteoporosis and sarcopenia 2020; (6(1)):1-7 doi:10.1016/j.afos.2020.02.002.

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.

Chotiyarnwong P, McCloskey EV

Nature reviews. Endocrinology 2020; (16(8)):437-447 doi:10.1038/s41574-020-0341-0.

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.

Burmester GR, Buttgereit F, Bernasconi C, et al.

Lancet (London, England) 2020; (396(10246)):267-276 doi:10.1016/S0140-6736(20)30636-X.

Management of glucocorticoid-induced osteoporosis.

Messina OD, Vidal LF, Wilman MV, et al.

Aging clinical and experimental research 2021; (33(4)):793-804 doi:10.1007/s40520-021-01823-0.

Understanding and Managing Corticosteroid-Induced Osteoporosis.

Kobza AO, Herman D, Papaioannou A, et al.

Open access rheumatology : research and reviews 2021; (13()):177-190 doi:10.2147/OARRR.S282606.

Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.

Abtahi S, Driessen JHM, Burden AM, et al.

Rheumatology (Oxford, England) 2022; (61(4)):1448-1458 doi:10.1093/rheumatology/keab548.

Paraspinal muscle fatty degeneration as a predictor of progressive vertebral collapse in osteoporotic vertebral compression fractures.

Jeon I, Kim SW, Yu D

The spine journal : official journal of the North American Spine Society 2022; (22(2)):313-320 doi:10.1016/j.spinee.2021.07.020.

Evaluation of care delivery by a novel multidisciplinary bone health clinic for patients at risk of glucocorticoid-induced osteoporosis.

Abdullah H, Koller G, Zuna I, et al.

Archives of osteoporosis 2021; (16(1)):108 doi:10.1007/s11657-021-00979-6.

[German Society of Rheumatology Recommendations for the management of glucocorticoid-induced Osteoporosis. German version].

Leipe J, Holle JU, Weseloh C, et al.

Zeitschrift fur Rheumatologie 2021; (80(7)):670-687 doi:10.1007/s00393-021-01028-w.

Clinical Utility of Trabecular Bone Score (TBS) in Fracture Risk Assessment of Patients with Rheumatic Diseases Treated with Glucocorticoids.

Nowakowska-Płaza A, Wroński J, Sudoł-Szopińska I, Głuszko P

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2021; (53(8)):499-503 doi:10.1055/a-1528-7261.

The incidence of medication-related osteonecrosis of the jaw following tooth extraction in patients prescribed oral bisphosphonates.

Barry E, Taylor T, Patel J, et al.

British dental journal 2021; doi:10.1038/s41415-021-3620-9.

Evaluation of Clinical Practice Guidelines on Fall Prevention and Management for Older Adults: A Systematic Review.

Montero-Odasso MM, Kamkar N, Pieruccini-Faria F, et al.

JAMA network open 2021; (4(12)):e2138911 doi:10.1001/jamanetworkopen.2021.38911.

[Glucocorticoid-induced osteoporosis-Focus treatment (part 1)].

Oelzner P, Eidner T, Pfeil A

Zeitschrift fur Rheumatologie 2022; (81(1)):57-66 doi:10.1007/s00393-021-01127-8.

[Glucocorticoid-induced osteoporosis-Focus treatment (part 2)].

Oelzner P, Eidner T, Pfeil A

Zeitschrift fur Rheumatologie 2022; (81(2)):125-133 doi:10.1007/s00393-021-01128-7.

The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials.

Liu ZM, Zhang M, Zong Y, et al.

PloS one 2022; (17(5)):e0267706 doi:10.1371/journal.pone.0267706.

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.

Laurent MR, Goemaere S, Verroken C, et al.

Frontiers in endocrinology 2022; (13()):908727 doi:10.3389/fendo.2022.908727.

Delayed complications of intradural cement leakage after percutaneous vertebroplasty: A case report.

Ma QH, Liu GP, Sun Q, Li JG

World journal of clinical cases 2022; (10(25)):8998-9003 doi:10.12998/wjcc.v10.i25.8998.

Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study.

Seki K, Kaneko T, Kamimoto A, et al.

Journal of dental sciences 2022; (17(4)):1619-1625 doi:10.1016/j.jds.2022.03.014.

Pathogenic mechanisms of glucocorticoid-induced osteoporosis.

Chen M, Fu W, Xu H, Liu CJ

Cytokine & growth factor reviews 2023; (70()):54-66 doi:10.1016/j.cytogfr.2023.03.002.

Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications.

Adami G, Fassio A, Rossini M, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(10)):1762-1769 doi:10.1002/art.42529.

Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management.

Anastasilaki E, Paccou J, Gkastaris K, Anastasilakis AD

Hormones (Athens, Greece) 2023; (22(4)):611-622 doi:10.1007/s42000-023-00491-1.

2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Humphrey MB, Russell L, Danila MI, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(12)):2088-2102 doi:10.1002/art.42646.

2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Humphrey MB, Russell L, Danila MI, et al.

Arthritis care & research 2023; (75(12)):2405-2419 doi:10.1002/acr.25240.

Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users.

Bjornsdottir HH, Einarsson ÓB, Gröndal G, Gudbjornsson B

SAGE open medicine 2024; (12()):20503121241235056 doi:10.1177/20503121241235056.

Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions.

Zerikly R, Demetriou EW

Women's health (London, England) 2024; (20()):17455057241231387 doi:10.1177/17455057241231387.

Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults: A Review.

Colón-Emeric CS, McDermott CL, Lee DS, Berry SD

JAMA 2024; (331(16)):1397-1406 doi:10.1001/jama.2024.1416.

Glucocorticoid prescribing in neurology.

Jones AP, Debono M, Walsh J, et al.

Practical neurology 2024; (24(4)):289-295 doi:10.1136/pn-2023-003855.

Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists.

Ishihara N, Yamashita S, Seiki S, et al.

Pharmacy (Basel, Switzerland) 2024; (12(3)) doi:10.3390/pharmacy12030080.

Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases.

Buttgereit F, Palmowski A, Bond M, et al.

Nature reviews. Rheumatology 2024; (20(7)):417-431 doi:10.1038/s41584-024-01120-w.

Interventions to Prevent Falls in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Guirguis-Blake JM, Perdue LA, Coppola EL, Bean SI

JAMA 2024; (332(1)):58-69 doi:10.1001/jama.2024.4166.

Thoracic Pyogenic Spondylitis Misdiagnosed As Osteoporotic Compression Fracture Status Post Vertebral Augmentation With Resultant Paraplegia: A Case Report.

Chen PW, Liu PC, Lee CC, Lam CT

Cureus 2024; (16(6)):e63497 doi:10.7759/cureus.63497.

[Translated article] Approach to the elderly patient with vertebral fracture due to bone fragility.

Hormigo-Sánchez AI, Neira-Álvarez M, Pareja-Sierra T

Revista espanola de cirugia ortopedica y traumatologia 2024; (68(6)):T572-T581 doi:10.1016/j.recot.2024.08.004.

Long-Term Bone Density Changes and Fracture Risk in Myasthenia Gravis: Implications for FRAX® Tool Application.

Konno S, Uchi T, Kihara H, Sugimoto H

Healthcare (Basel, Switzerland) 2024; (12(17)) doi:10.3390/healthcare12171793.

Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society.

Paccou J, Yavropoulou MP, Naciu AM, et al.

European journal of endocrinology 2024; (191(6)):G1-G17 doi:10.1093/ejendo/lvae146.

Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).

Bhattoa HP, Vasikaran S, Trifonidi I, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2025; (36(4)):579-608 doi:10.1007/s00198-025-07422-3.

Older Adults' and Professionals' Attitudes Towards Stair-Fall Prevention Interventions.

Mulliner E, O'Brien TD, Maliene V, et al.

Healthcare (Basel, Switzerland) 2025; (13(11)) doi:10.3390/healthcare13111324.

Epidural haematoma following vertebroplasty for osteoporosis compression fracture: A case report.

Ye Y, Deng F, Feng Y, et al.

International journal of surgery case reports 2025; (134()):111727 doi:10.1016/j.ijscr.2025.111727.

Practical guidance for stopping glucocorticoids.

Khalili F, Burt MG

Australian prescriber 2025; (48(4)):116-121 doi:10.18773/austprescr.2025.037.

Intradural Bone Cement Leakage After Vertebroplasty, An Under-Recognized Potential Catastrophe: A Case Report.

Liao W, Hou Z, Gao Y

International medical case reports journal 2025; (18()):1063-1069 doi:10.2147/IMCRJ.S535207.

Updates on the Role of DXA in the Evaluation and Monitoring of Osteoporosis.

Anupama S, Lim SY, Bolster MB

Current rheumatology reports 2025; (27(1)):38 doi:10.1007/s11926-025-01205-9.

The impact of frailty and fear of falling on health-related quality of life in older adults with osteoporosis: a cross-sectional study.

Zhang L, Liu L, Chen C, et al.

BMC geriatrics 2025; (25(1)):938 doi:10.1186/s12877-025-06625-x.

Weaning patients off long-term prednisolone: a survey of physicians' practice in the UK and Southeast Asia.

Lazarus K, Eng PC, Narula K, et al.

BMJ open 2025; (15(12)):e107269 doi:10.1136/bmjopen-2025-107269.

Drug-Induced Osteoporosis.

Gasser RW, Kocijan R, Zendeli A, Resch H

Journal of clinical medicine 2026; (15(3)) doi:10.3390/jcm15030993.

Clinical impact of acute symptomatic vertebral fractures in the United States: A patient survey and chart review.

Ing SW, McDermott M, Yeh E, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2026; doi:10.1007/s00198-026-07951-5.

Glucocorticoid-Induced Osteoporosis: Pathogenesis, the Impact of Different Administration Routes on Bone Mineral Density, and Fracture Risk and Treatment Options-A Narrative Review.

Kapszewicz M, Michalska-Kasiczak M, Sewerynek E

Journal of clinical medicine 2026; (15(7)) doi:10.3390/jcm15072488.

Concomitant osteoporotic vertebral compression fracture and infectious spondylitis in a patient with herpes zoster: A case report.

Lee J, Lee CH

Medicine 2026; (105(17)):e48493 doi:10.1097/MD.0000000000048493.

Update on Glucocorticoid-Induced Osteoporosis: Emerging Therapeutic Strategies.

Cho SK, Sung YK

Endocrinology and metabolism (Seoul, Korea) 2026; (41(3)):358-366 doi:10.3803/EnM.2026.3006.